CL2022002292A1 - Acetato de sodio y composiciones farmacéuticas del mismo - Google Patents

Acetato de sodio y composiciones farmacéuticas del mismo

Info

Publication number
CL2022002292A1
CL2022002292A1 CL2022002292A CL2022002292A CL2022002292A1 CL 2022002292 A1 CL2022002292 A1 CL 2022002292A1 CL 2022002292 A CL2022002292 A CL 2022002292A CL 2022002292 A CL2022002292 A CL 2022002292A CL 2022002292 A1 CL2022002292 A1 CL 2022002292A1
Authority
CL
Chile
Prior art keywords
pharmaceutical compositions
sodium acetate
methods
invention further
further relates
Prior art date
Application number
CL2022002292A
Other languages
English (en)
Inventor
Buschmann Helmut
Goldner Thomas
Redmer Jessica
Hawe Andrea
Lucke Matthias
Hohmann Dorothea
rosa Monica
Original Assignee
Aic246 Ag & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aic246 Ag & Co Kg filed Critical Aic246 Ag & Co Kg
Publication of CL2022002292A1 publication Critical patent/CL2022002292A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a nuevas composiciones farmacéuticas estables que contienen 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2- metoxi-5-(trifluorometil )fenil]-4H-quinazolin-4-il] acetato de sodio que están 10 esencialmente libres de agentes solubilizantes formadores de complejos, tales como PEG, ciclodextrina, lisina, arginina, en particular HPBCD. La invención se refiere además a métodos de preparación de dichas composiciones farmacéuticas. La invención se refiere además al uso de dichas composiciones farmacéuticas en métodos de tratamiento y/o como profiláctico de 15 enfermedades, particularmente su uso como un antivírico, preferentemente contra citomegalovirus.
CL2022002292A 2020-02-27 2022-08-22 Acetato de sodio y composiciones farmacéuticas del mismo CL2022002292A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20159699 2020-02-27

Publications (1)

Publication Number Publication Date
CL2022002292A1 true CL2022002292A1 (es) 2023-02-03

Family

ID=69742703

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022002292A CL2022002292A1 (es) 2020-02-27 2022-08-22 Acetato de sodio y composiciones farmacéuticas del mismo

Country Status (19)

Country Link
US (1) US20230095980A1 (es)
EP (1) EP4110302A1 (es)
JP (1) JP2023520627A (es)
KR (1) KR20220148861A (es)
CN (1) CN115427024A (es)
AR (1) AR122386A1 (es)
AU (1) AU2021228240A1 (es)
BR (1) BR112022016931A2 (es)
CA (1) CA3169084A1 (es)
CL (1) CL2022002292A1 (es)
CO (1) CO2022012032A2 (es)
CU (1) CU20220048A7 (es)
EC (1) ECSP22066676A (es)
IL (1) IL295682A (es)
MX (1) MX2022010443A (es)
PE (1) PE20230513A1 (es)
TW (1) TW202140021A (es)
UY (1) UY39099A (es)
WO (1) WO2021170878A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114942278B (zh) * 2022-04-12 2023-09-08 山东诚创蓝海医药科技有限公司 来特莫韦中间体二d-(+)-二对甲基苯甲酰酒石酸乙酸乙酯络合物有关物质的分析方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE102012101680A1 (de) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101659A1 (de) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats
CN109966244A (zh) * 2017-12-27 2019-07-05 天津耀辰实业发展有限公司 一种含有乐特莫韦的药物组合物

Also Published As

Publication number Publication date
TW202140021A (zh) 2021-11-01
JP2023520627A (ja) 2023-05-18
ECSP22066676A (es) 2022-12-30
KR20220148861A (ko) 2022-11-07
CU20220048A7 (es) 2023-04-10
EP4110302A1 (en) 2023-01-04
BR112022016931A2 (pt) 2022-10-11
MX2022010443A (es) 2022-10-18
UY39099A (es) 2021-08-31
AR122386A1 (es) 2022-09-07
WO2021170878A1 (en) 2021-09-02
US20230095980A1 (en) 2023-03-30
CO2022012032A2 (es) 2022-11-29
AU2021228240A1 (en) 2022-10-20
CN115427024A (zh) 2022-12-02
PE20230513A1 (es) 2023-03-24
IL295682A (en) 2022-10-01
CA3169084A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
CL2022002293A1 (es) Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- 5 (trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio.
CY1121782T1 (el) Διαδικασια για ξηρανση της bibw2992, tων αλατων αυτης και στερεων φαρμακευτικων σκευασματων που περιλαμβανουν αυτο το δραστικο συστατικο
CY1124690T1 (el) Σκευασματα ενδοφλεβιου διαλυματος ποσακοναζολης σταθεροποιημενα με υποκατεστημενη βητα-κυκλοδεξτρινη
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
CL2022002292A1 (es) Acetato de sodio y composiciones farmacéuticas del mismo
CY1121910T1 (el) Φαρμακευτικο παρασκευασμα που περιεχει παραγωγο διυδροκιναζολινης με αντιϊικη δραση
ATE431149T1 (de) Analoge der barbitursäure als therapeutische wirkstoffe
MX2018003452A (es) Composiciones de taxano orales y metodos.
Fletcher et al. A novel antiviral formulation inhibits a range of enveloped viruses
PH12019550163A1 (en) Npra agonists, compositions, and uses thereof
BRPI1008815A2 (pt) composições farmacêuticas compreendendo peptídeos inibidores de tgf-beta1
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
PE20212270A1 (es) Forma de un compuesto que tiene biodisponibilidad mejorada y formulaciones de las mismas
TR201901792T4 (tr) Yeni (trimetoksifenilamino)pirimidinil formülasyonları.
BR112015013625A2 (pt) adjuvante de vacinação, preparação e vacinas contendo o mesmo
MX2020011735A (es) Composicion de cuidado bucal para aliviar la hiperestesia dentinaria.
MX2007005059A (es) Composicion cosmetica que comprende un ester de sorbitol oxietilenado y una ciclodextrina, procedimientos y usos.
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
CA3242115A1 (en) Pharmaceutical compositions comprising 2-[(4s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4h-quinazolin-4-yl]acetate and potassium ions
AR062674A1 (es) Formulacion acuosa que comprende un agente antitumoral
CO2022012006A2 (es) Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acético
EA202000016A1 (ru) Стабильные янтарнокислые соли гексапептида
AR127281A1 (es) Dendrones peptídicos y métodos de uso de los mismos
UY39083A (es) Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria